. 2019 Aug; 10:1719.
doi: 10.3389/fimmu.2019.01719.

T Cell Dysfunction in Cancer Immunity and Immunotherapy

Anliang Xia 1 Yan Zhang 2 Jiang Xu 3 Tailang Yin 4 Xiao-Jie Lu 1 
  • PMID: 31379886
  •     212 References
  •     89 citations


In cancer, T cells become dysfunctional owing to persistent antigen exposure. Dysfunctional T cells are characterized by reduced proliferative capacity, decreased effector function, and overexpression of multiple inhibitory receptors. Due to the presence of various inhibitory signals in the complex tumor microenvironment, tumor-specific T cells have distinct dysfunction states. Therapeutic reactivation of tumor-specific T cells has yielded good results in cancer patients. Here, we review the hallmarks of T cell dysfunction in cancer. Also, we discuss the relationship between T cell dysfunction and cancer immunotherapy.

Keywords: T cell dysfunction; cancer; immunity; immunotherapy; tumor microenvironment.

T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function.
S Sharma, M Stolina, +4 authors, S M Dubinett.
J Immunol, 1999 Oct 21; 163(9). PMID: 10528207
Engagement of the OX-40 receptor in vivo enhances antitumor immunity.
A D Weinberg, M M Rivera, +7 authors, J Shields.
J Immunol, 2000 Feb 05; 164(4). PMID: 10657670
Highly Cited.
Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth.
J Kjaergaard, J Tanaka, +3 authors, S Shu.
Cancer Res, 2000 Oct 18; 60(19). PMID: 11034096
Interleukin-10 and the interleukin-10 receptor.
K W Moore, R de Waal Malefyt, R L Coffman, A O'Garra.
Annu Rev Immunol, 2001 Mar 13; 19. PMID: 11244051
Highly Cited. Review.
Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ.
S Fujii, K Shimizu, T Shimizu, M T Lotze.
Blood, 2001 Sep 25; 98(7). PMID: 11568001
Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength.
Jackson G Egen, James P Allison.
Immunity, 2002 Feb 05; 16(1). PMID: 11825563
Highly Cited.
The CD28 signaling pathway regulates glucose metabolism.
Kenneth A Frauwirth, James L Riley, +6 authors, Craig B Thompson.
Immunity, 2002 Jul 18; 16(6). PMID: 12121659
Highly Cited.
Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.
E John Wherry, Joseph N Blattman, +2 authors, Rafi Ahmed.
J Virol, 2003 Mar 29; 77(8). PMID: 12663797    Free PMC article.
Highly Cited.
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
Cristina Bottino, Roberta Castriconi, +11 authors, Alessandro Moretta.
J Exp Med, 2003 Aug 13; 198(4). PMID: 12913096    Free PMC article.
Highly Cited.
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.
Catherine Uyttenhove, Luc Pilotte, +5 authors, Benoît J Van den Eynde.
Nat Med, 2003 Sep 23; 9(10). PMID: 14502282
Highly Cited.
Control of effector CD8+ T cell function by the transcription factor Eomesodermin.
Erika L Pearce, Alan C Mullen, +14 authors, Steven L Reiner.
Science, 2003 Nov 08; 302(5647). PMID: 14605368
Highly Cited.
Interleukin-10 and related cytokines and receptors.
Sidney Pestka, Christopher D Krause, +3 authors, Paul B Fisher.
Annu Rev Immunol, 2004 Mar 23; 22. PMID: 15032600
Highly Cited. Review.
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.
Mary Jo Turk, José A Guevara-Patiño, +3 authors, Alan N Houghton.
J Exp Med, 2004 Sep 24; 200(6). PMID: 15381730    Free PMC article.
Highly Cited.
Arginine and cancer.
D Scott Lind.
J Nutr, 2004 Oct 07; 134(10 Suppl). PMID: 15465796
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.
Andrew M Intlekofer, Naofumi Takemoto, +15 authors, Steven L Reiner.
Nat Immunol, 2005 Nov 08; 6(12). PMID: 16273099
Highly Cited.
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.
Chen Zhu, Ana C Anderson, +6 authors, Vijay K Kuchroo.
Nat Immunol, 2005 Nov 16; 6(12). PMID: 16286920
Highly Cited.
The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease.
V H Haase.
Kidney Int, 2006 Mar 15; 69(8). PMID: 16531988
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
Cheryl L Day, Daniel E Kaufmann, +19 authors, Bruce D Walker.
Nature, 2006 Aug 22; 443(7109). PMID: 16921384
Highly Cited.
Inhibitory effect of tumor cell-derived lactic acid on human T cells.
Karin Fischer, Petra Hoffmann, +14 authors, Marina Kreutz.
Blood, 2007 Jan 27; 109(9). PMID: 17255361
Highly Cited.
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.
Arlene H Sharpe, E John Wherry, Rafi Ahmed, Gordon J Freeman.
Nat Immunol, 2007 Feb 17; 8(3). PMID: 17304234
Highly Cited. Review.
Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection.
Paola Agnellini, Petra Wolint, +3 authors, Annette Oxenius.
Proc Natl Acad Sci U S A, 2007 Mar 16; 104(11). PMID: 17360564    Free PMC article.
Indoleamine 2,3-dioxygenase and tumor-induced tolerance.
David H Munn, Andrew L Mellor.
J Clin Invest, 2007 May 04; 117(5). PMID: 17476344    Free PMC article.
Highly Cited. Review.
Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling.
Tatiana Raskovalova, Anna Lokshin, +5 authors, Elieser Gorelik.
Cancer Res, 2007 Jun 19; 67(12). PMID: 17575165
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
Madhav D Sharma, Babak Baban, +7 authors, David H Munn.
J Clin Invest, 2007 Aug 22; 117(9). PMID: 17710230    Free PMC article.
Highly Cited.
Molecular signature of CD8+ T cell exhaustion during chronic viral infection.
E John Wherry, Sang-Jun Ha, +7 authors, Rafi Ahmed.
Immunity, 2007 Oct 24; 27(4). PMID: 17950003
Highly Cited.
The inhibitory cytokine IL-35 contributes to regulatory T-cell function.
Lauren W Collison, Creg J Workman, +7 authors, Dario A A Vignali.
Nature, 2007 Nov 23; 450(7169). PMID: 18033300
Highly Cited.
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma.
Sergio A Quezada, Karl S Peggs, +3 authors, James P Allison.
J Exp Med, 2008 Aug 30; 205(9). PMID: 18725522    Free PMC article.
Highly Cited.
NFATc1 regulates PD-1 expression upon T cell activation.
Kenneth J Oestreich, Hyesuk Yoon, Rafi Ahmed, Jeremy M Boss.
J Immunol, 2008 Sep 20; 181(7). PMID: 18802087    Free PMC article.
Highly Cited.
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.
Xin Yu, Kristin Harden, +9 authors, Jane L Grogan.
Nat Immunol, 2008 Nov 18; 10(1). PMID: 19011627
Highly Cited.
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.
Shawn D Blackburn, Haina Shin, +7 authors, E John Wherry.
Nat Immunol, 2008 Dec 02; 10(1). PMID: 19043418    Free PMC article.
Highly Cited.
Myeloid-derived suppressor cells as regulators of the immune system.
Dmitry I Gabrilovich, Srinivas Nagaraj.
Nat Rev Immunol, 2009 Feb 07; 9(3). PMID: 19197294    Free PMC article.
Highly Cited. Review.
Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.
Paulo C Rodriguez, Marc S Ernstoff, +4 authors, Augusto C Ochoa.
Cancer Res, 2009 Feb 10; 69(4). PMID: 19201693    Free PMC article.
Highly Cited.
PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.
Julien Fourcade, Pavol Kudela, +9 authors, Hassane M Zarour.
J Immunol, 2009 Apr 22; 182(9). PMID: 19380770    Free PMC article.
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.
Mojgan Ahmadzadeh, Laura A Johnson, +4 authors, Steven A Rosenberg.
Blood, 2009 May 09; 114(8). PMID: 19423728    Free PMC article.
Highly Cited.
Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion.
Christine M Bucks, Jillian A Norton, +2 authors, Peter D Katsikis.
J Immunol, 2009 May 21; 182(11). PMID: 19454664    Free PMC article.
L-arginine deprivation impairs Leishmania major-specific T-cell responses.
Markus Munder, Beak-San Choi, Matthew Rogers, Pascale Kropf.
Eur J Immunol, 2009 Jul 29; 39(8). PMID: 19637195    Free PMC article.
A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection.
Haina Shin, Shawn D Blackburn, +4 authors, E John Wherry.
Immunity, 2009 Aug 12; 31(2). PMID: 19664943    Free PMC article.
Highly Cited.
Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2.
Jennifer K Mulligan, Steven A Rosenzweig, M Rita I Young.
J Immunother, 2010 Feb 11; 33(2). PMID: 20145550    Free PMC article.
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.
Michael A Curran, Welby Montalvo, Hideo Yagita, James P Allison.
Proc Natl Acad Sci U S A, 2010 Feb 18; 107(9). PMID: 20160101    Free PMC article.
Highly Cited.
Control of immunity by the TNFR-related molecule OX40 (CD134).
Michael Croft.
Annu Rev Immunol, 2010 Mar 24; 28. PMID: 20307208    Free PMC article.
Highly Cited. Review.
Inflammatory cytokines as a third signal for T cell activation.
Julie M Curtsinger, Matthew F Mescher.
Curr Opin Immunol, 2010 Apr 07; 22(3). PMID: 20363604    Free PMC article.
Highly Cited. Review.
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
Junko Matsuzaki, Sacha Gnjatic, +9 authors, Kunle Odunsi.
Proc Natl Acad Sci U S A, 2010 Apr 14; 107(17). PMID: 20385810    Free PMC article.
Highly Cited.
Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, +26 authors, Walter J Urba.
N Engl J Med, 2010 Jun 08; 363(8). PMID: 20525992    Free PMC article.
Highly Cited.
TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity.
Gordon J Freeman, Jose M Casasnovas, Dale T Umetsu, Rosemarie H DeKruyff.
Immunol Rev, 2010 Jun 12; 235(1). PMID: 20536563    Free PMC article.
Highly Cited. Review.
Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation.
Erikka L Carr, Alina Kelman, +5 authors, Kenneth A Frauwirth.
J Immunol, 2010 Jun 18; 185(2). PMID: 20554958    Free PMC article.
Highly Cited.
Generation of effector CD8+ T cells and their conversion to memory T cells.
Weiguo Cui, Susan M Kaech.
Immunol Rev, 2010 Jul 20; 236. PMID: 20636815    Free PMC article.
Highly Cited. Review.
The PD-1 pathway in tolerance and autoimmunity.
Loise M Francisco, Peter T Sage, Arlene H Sharpe.
Immunol Rev, 2010 Jul 20; 236. PMID: 20636820    Free PMC article.
Highly Cited. Review.
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients.
Julien Fourcade, Zhaojun Sun, +6 authors, Hassane M Zarour.
J Exp Med, 2010 Sep 08; 207(10). PMID: 20819923    Free PMC article.
Highly Cited.
Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche.
Arnob Banerjee, Scott M Gordon, +5 authors, Steven L Reiner.
J Immunol, 2010 Oct 12; 185(9). PMID: 20935204    Free PMC article.
Highly Cited.
Cutting edge: TIGIT has T cell-intrinsic inhibitory functions.
Nicole Joller, Jason P Hafler, +5 authors, Vijay K Kuchroo.
J Immunol, 2011 Jan 05; 186(3). PMID: 21199897    Free PMC article.
Highly Cited.
IFN-α directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity.
Seigo Terawaki, Shunsuke Chikuma, +4 authors, Tasuku Honjo.
J Immunol, 2011 Jan 26; 186(5). PMID: 21263073
Highly Cited.
Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults.
Jaikumar Duraiswamy, Chris C Ibegbu, +11 authors, Rafi Ahmed.
J Immunol, 2011 Mar 09; 186(7). PMID: 21383243    Free PMC article.
Highly Cited.
Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?
Arne N Akbar, Sian M Henson.
Nat Rev Immunol, 2011 Mar 26; 11(4). PMID: 21436838
Highly Cited.
Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion.
Béatrice Dirat, Ludivine Bochet, +11 authors, Catherine Muller.
Cancer Res, 2011 Apr 05; 71(7). PMID: 21459803
Highly Cited.
Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients.
Lukas Baitsch, Petra Baumgaertner, +9 authors, Daniel E Speiser.
J Clin Invest, 2011 May 11; 121(6). PMID: 21555851    Free PMC article.
Highly Cited.
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
Caroline Robert, Luc Thomas, +21 authors, Jedd D Wolchok.
N Engl J Med, 2011 Jun 07; 364(26). PMID: 21639810
Highly Cited.
T cell exhaustion.
E John Wherry.
Nat Immunol, 2011 Jul 09; 12(6). PMID: 21739672
Highly Cited. Review.
Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.
Ben Youngblood, Kenneth J Oestreich, +9 authors, Rafi Ahmed.
Immunity, 2011 Sep 29; 35(3). PMID: 21943489    Free PMC article.
Highly Cited.
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.
Kristin M Nieman, Hilary A Kenny, +11 authors, Ernst Lengyel.
Nat Med, 2011 Nov 01; 17(11). PMID: 22037646    Free PMC article.
Highly Cited.
IL-10 elicits IFNγ-dependent tumor immune surveillance.
John B Mumm, Jan Emmerich, +28 authors, Martin Oft.
Cancer Cell, 2011 Dec 17; 20(6). PMID: 22172723
Highly Cited.
Activated CD69+ T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages.
Qiyi Zhao, Dong-Ming Kuang, +4 authors, Limin Zheng.
J Immunol, 2011 Dec 21; 188(3). PMID: 22184722
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.
Seng-Ryong Woo, Meghan E Turnis, +18 authors, Dario A A Vignali.
Cancer Res, 2011 Dec 22; 72(4). PMID: 22186141    Free PMC article.
Highly Cited.
CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.
Julien Fourcade, Zhaojun Sun, +7 authors, Hassane M Zarour.
Cancer Res, 2011 Dec 30; 72(4). PMID: 22205715    Free PMC article.
Highly Cited.
Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice.
Dhanalakshmi Chinnasamy, Zhiya Yu, +4 authors, Steven A Rosenberg.
Clin Cancer Res, 2012 Feb 01; 18(6). PMID: 22291136    Free PMC article.
Highly Cited.
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape.
Janis M Taube, Robert A Anders, +8 authors, Lieping Chen.
Sci Transl Med, 2012 Mar 31; 4(127). PMID: 22461641    Free PMC article.
Highly Cited.
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.
Tadashi Yokosuka, Masako Takamatsu, +3 authors, Takashi Saito.
J Exp Med, 2012 May 30; 209(6). PMID: 22641383    Free PMC article.
Highly Cited.
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Suzanne L Topalian, F Stephen Hodi, +27 authors, Mario Sznol.
N Engl J Med, 2012 Jun 05; 366(26). PMID: 22658127    Free PMC article.
Highly Cited.
Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway.
Xian-zong Ye, Sen-lin Xu, +14 authors, Xiu-wu Bian.
J Immunol, 2012 Jun 06; 189(1). PMID: 22664874
Highly Cited.
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1.
Shigeki Chiba, Muhammad Baghdadi, +12 authors, Masahisa Jinushi.
Nat Immunol, 2012 Jul 31; 13(9). PMID: 22842346    Free PMC article.
Highly Cited.
HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts.
Song Yi Ko, Nicolas Barengo, +4 authors, Honami Naora.
J Clin Invest, 2012 Sep 05; 122(10). PMID: 22945634    Free PMC article.
Transcriptional control of effector and memory CD8+ T cell differentiation.
Susan M Kaech, Weiguo Cui.
Nat Rev Immunol, 2012 Oct 20; 12(11). PMID: 23080391    Free PMC article.
Highly Cited. Review.
Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion.
Michael Platten, Wolfgang Wick, Benoît J Van den Eynde.
Cancer Res, 2012 Oct 24; 72(21). PMID: 23090118
Highly Cited. Review.
VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer.
Magali Terme, Simon Pernot, +7 authors, Julien Taieb.
Cancer Res, 2012 Oct 31; 73(2). PMID: 23108136
Highly Cited.
Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory.
Travis A Doering, Alison Crawford, +3 authors, E John Wherry.
Immunity, 2012 Nov 20; 37(6). PMID: 23159438    Free PMC article.
Highly Cited.
Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection.
Michael A Paley, Daniela C Kroy, +8 authors, E John Wherry.
Science, 2012 Dec 01; 338(6111). PMID: 23197535    Free PMC article.
Highly Cited.
Metabolic regulation of T lymphocytes.
Nancie J MacIver, Ryan D Michalek, Jeffrey C Rathmell.
Annu Rev Immunol, 2013 Jan 10; 31. PMID: 23298210    Free PMC article.
Highly Cited. Review.
Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation.
Youn Soo Choi, Danelle Eto, +2 authors, Shane Crotty.
J Immunol, 2013 Mar 01; 190(7). PMID: 23447690    Free PMC article.
Highly Cited.
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy.
Chao Ma, Ann F Cheung, +12 authors, James R Heath.
Cancer Discov, 2013 Mar 23; 3(4). PMID: 23519018    Free PMC article.
Persistent LCMV infection is controlled by blockade of type I interferon signaling.
John R Teijaro, Cherie Ng, +6 authors, Michael B A Oldstone.
Science, 2013 Apr 13; 340(6129). PMID: 23580529    Free PMC article.
Highly Cited.
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
Omid Hamid, Caroline Robert, +23 authors, Antoni Ribas.
N Engl J Med, 2013 Jun 04; 369(2). PMID: 23724846    Free PMC article.
Highly Cited.
Nivolumab plus ipilimumab in advanced melanoma.
Jedd D Wolchok, Harriet Kluger, +21 authors, Mario Sznol.
N Engl J Med, 2013 Jun 04; 369(2). PMID: 23724867    Free PMC article.
Highly Cited.
Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
Stephen Yiu Chuen Choi, Colin C Collins, Peter W Gout, Yuzhuo Wang.
J Pathol, 2013 Jun 05; 230(4). PMID: 23729358    Free PMC article.
Highly Cited. Review.
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.
Rikke B Holmgaard, Dmitriy Zamarin, +2 authors, James P Allison.
J Exp Med, 2013 Jun 12; 210(7). PMID: 23752227    Free PMC article.
Highly Cited.
Cutting edge: Prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cells.
Ben Youngblood, Alessandra Noto, +14 authors, Daniel E Kaufmann.
J Immunol, 2013 Jun 19; 191(2). PMID: 23772031    Free PMC article.
Highly Cited.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies.
Yannick Bulliard, Rose Jolicoeur, +6 authors, Jennifer L Brogdon.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897982    Free PMC article.
Highly Cited.
Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.
Stefani Spranger, Robbert M Spaapen, +4 authors, Thomas F Gajewski.
Sci Transl Med, 2013 Aug 30; 5(200). PMID: 23986400    Free PMC article.
Highly Cited.
Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen.
Andrew L Doedens, Anthony T Phan, +5 authors, Ananda W Goldrath.
Nat Immunol, 2013 Oct 01; 14(11). PMID: 24076634    Free PMC article.
Highly Cited.
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.
Daisuke Sugiyama, Hiroyoshi Nishikawa, +10 authors, Shimon Sakaguchi.
Proc Natl Acad Sci U S A, 2013 Oct 16; 110(44). PMID: 24127572    Free PMC article.
Highly Cited.
Tolerance and exhaustion: defining mechanisms of T cell dysfunction.
Andrea Schietinger, Philip D Greenberg.
Trends Immunol, 2013 Nov 12; 35(2). PMID: 24210163    Free PMC article.
Highly Cited. Review.
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application.
Taku Okazaki, Shunsuke Chikuma, +2 authors, Tasuku Honjo.
Nat Immunol, 2013 Nov 19; 14(12). PMID: 24240160
Highly Cited. Review.
Sprouty-2 regulates HIV-specific T cell polyfunctionality.
Yen-Ling Chiu, Liang Shan, +11 authors, Jonathan P Schneck.
J Clin Invest, 2013 Dec 03; 124(1). PMID: 24292711    Free PMC article.
Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatin.
Huafeng Wei, Likun Zhao, +8 authors, Yajun Guo.
PLoS One, 2013 Dec 25; 8(12). PMID: 24367702    Free PMC article.
Regulatory T cells in cancer immunotherapy.
Hiroyoshi Nishikawa, Shimon Sakaguchi.
Curr Opin Immunol, 2014 Jan 15; 27. PMID: 24413387
Highly Cited. Review.
Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues.
Tetsuya Honda, Jackson G Egen, +3 authors, Ronald N Germain.
Immunity, 2014 Jan 21; 40(2). PMID: 24440150    Free PMC article.
Highly Cited.
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
Ping Shen, Toralf Roch, +28 authors, Simon Fillatreau.
Nature, 2014 Feb 28; 507(7492). PMID: 24572363    Free PMC article.
Highly Cited.
The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells.
Makoto Kurachi, R Anthony Barnitz, +9 authors, W Nicholas Haining.
Nat Immunol, 2014 Mar 04; 15(4). PMID: 24584090    Free PMC article.
Highly Cited.
Emerging roles of lymphatic endothelium in regulating adaptive immunity.
Catherine M Card, Shann S Yu, Melody A Swartz.
J Clin Invest, 2014 Mar 05; 124(3). PMID: 24590280    Free PMC article.
Highly Cited. Review.
OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy.
Yannick Bulliard, Rose Jolicoeur, +3 authors, Jennifer L Brogdon.
Immunol Cell Biol, 2014 Apr 16; 92(6). PMID: 24732076
Highly Cited.
Interleukin-35 induces regulatory B cells that suppress autoimmune disease.
Ren-Xi Wang, Cheng-Rong Yu, +6 authors, Charles E Egwuagu.
Nat Med, 2014 Apr 20; 20(6). PMID: 24743305    Free PMC article.
Highly Cited.
Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses.
Nicole Joller, Ester Lozano, +13 authors, Vijay K Kuchroo.
Immunity, 2014 Apr 22; 40(4). PMID: 24745333    Free PMC article.
Highly Cited.
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors.
Gregory T Motz, Stephen P Santoro, +7 authors, George Coukos.
Nat Med, 2014 May 06; 20(6). PMID: 24793239    Free PMC article.
Highly Cited.
Metabolism of stromal and immune cells in health and disease.
Bart Ghesquière, Brian W Wong, Anna Kuchnio, Peter Carmeliet.
Nature, 2014 Jul 11; 511(7508). PMID: 25008522
Highly Cited. Review.
Programmed cell death 1-directed immunotherapy for enhancing T-cell function.
Koichi Araki, Ben Youngblood, Rafi Ahmed.
Cold Spring Harb Symp Quant Biol, 2013 Jan 01; 78. PMID: 25028401
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.
Caroline Robert, Antoni Ribas, +22 authors, Adil Daud.
Lancet, 2014 Jul 19; 384(9948). PMID: 25034862
Highly Cited.
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid.
Oscar R Colegio, Ngoc-Quynh Chu, +10 authors, Ruslan Medzhitov.
Nature, 2014 Jul 22; 513(7519). PMID: 25043024    Free PMC article.
Highly Cited.
Extracellular adenosine-mediated modulation of regulatory T cells.
Akio Ohta, Michail Sitkovsky.
Front Immunol, 2014 Jul 30; 5. PMID: 25071765    Free PMC article.
Highly Cited.
Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.
Pia Kvistborg, Daisy Philips, +13 authors, Ton N Schumacher.
Sci Transl Med, 2014 Sep 19; 6(254). PMID: 25232180
Highly Cited.
The aryl hydrocarbon receptor meets immunology: friend or foe? A little of both.
Walker Julliard, John H Fechner, Joshua D Mezrich.
Front Immunol, 2014 Oct 18; 5. PMID: 25324842    Free PMC article.
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.
Yu-Hwa Huang, Chen Zhu, +21 authors, Richard S Blumberg.
Nature, 2014 Nov 05; 517(7534). PMID: 25363763    Free PMC article.
Highly Cited.
Combination of 4-1BB agonist and PD-1 antagonist promotes antitumor effector/memory CD8 T cells in a poorly immunogenic tumor model.
Shihao Chen, Li-Fen Lee, +12 authors, John C Lin.
Cancer Immunol Res, 2014 Nov 13; 3(2). PMID: 25387892
Highly Cited.
The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection.
Matthew M Staron, Simon M Gray, +6 authors, Susan M Kaech.
Immunity, 2014 Dec 04; 41(5). PMID: 25464856    Free PMC article.
Highly Cited.
The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function.
Robert J Johnston, Laetitia Comps-Agrar, +9 authors, Jane L Grogan.
Cancer Cell, 2014 Dec 04; 26(6). PMID: 25465800
Highly Cited.
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
Stephen M Ansell, Alexander M Lesokhin, +16 authors, Philippe Armand.
N Engl J Med, 2014 Dec 09; 372(4). PMID: 25482239    Free PMC article.
Highly Cited.
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.
Thibault Voron, Orianne Colussi, +15 authors, Magali Terme.
J Exp Med, 2015 Jan 21; 212(2). PMID: 25601652    Free PMC article.
Highly Cited.
Type I interferons in infectious disease.
Finlay McNab, Katrin Mayer-Barber, +2 authors, Anne O'Garra.
Nat Rev Immunol, 2015 Jan 24; 15(2). PMID: 25614319    Free PMC article.
Highly Cited. Review.
The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells.
Gustavo J Martinez, Renata M Pereira, +13 authors, Anjana Rao.
Immunity, 2015 Feb 15; 42(2). PMID: 25680272    Free PMC article.
Highly Cited.
Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.
Kazuhiro Tanaka, Takashi Sasayama, +14 authors, Eiji Kohmura.
J Clin Invest, 2015 Mar 24; 125(4). PMID: 25798620    Free PMC article.
Highly Cited.
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation.
Nikolaos Patsoukis, Kankana Bardhan, +9 authors, Vassiliki A Boussiotis.
Nat Commun, 2015 Mar 27; 6. PMID: 25809635    Free PMC article.
Highly Cited.
The future of immune checkpoint therapy.
Padmanee Sharma, James P Allison.
Science, 2015 Apr 04; 348(6230). PMID: 25838373
Highly Cited. Review.
TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.
Joe-Marc Chauvin, Ornella Pagliano, +8 authors, Hassane M Zarour.
J Clin Invest, 2015 Apr 14; 125(5). PMID: 25866972    Free PMC article.
Highly Cited.
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
James Larkin, Vanna Chiarion-Sileni, +28 authors, Jedd D Wolchok.
N Engl J Med, 2015 Jun 02; 373(1). PMID: 26027431    Free PMC article.
Highly Cited.
The paradoxical role of IL-10 in immunity and cancer.
Mark H Mannino, Ziwen Zhu, +3 authors, Yujiang Fang.
Cancer Lett, 2015 Jul 19; 367(2). PMID: 26188281
Highly Cited. Review.
Molecular and cellular insights into T cell exhaustion.
E John Wherry, Makoto Kurachi.
Nat Rev Immunol, 2015 Jul 25; 15(8). PMID: 26205583    Free PMC article.
Highly Cited. Review.
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.
Chih-Hao Chang, Jing Qiu, +11 authors, Erika L Pearce.
Cell, 2015 Sep 01; 162(6). PMID: 26321679    Free PMC article.
Highly Cited.
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.
Ping-Chih Ho, Jessica Dauz Bihuniak, +15 authors, Susan M Kaech.
Cell, 2015 Sep 01; 162(6). PMID: 26321681    Free PMC article.
Highly Cited.
Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance.
Willy Hugo, Hubing Shi, +10 authors, Roger S Lo.
Cell, 2015 Sep 12; 162(6). PMID: 26359985    Free PMC article.
Highly Cited.
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
Robert J Motzer, Bernard Escudier, +25 authors, CheckMate 025 Investigators.
N Engl J Med, 2015 Sep 26; 373(19). PMID: 26406148    Free PMC article.
Highly Cited.
TIGIT predominantly regulates the immune response via regulatory T cells.
Sema Kurtulus, Kaori Sakuishi, +6 authors, Ana C Anderson.
J Clin Invest, 2015 Sep 29; 125(11). PMID: 26413872    Free PMC article.
Highly Cited.
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction.
Ende Zhao, Tomasz Maj, +22 authors, Weiping Zou.
Nat Immunol, 2015 Nov 03; 17(1). PMID: 26523864    Free PMC article.
Highly Cited.
Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy.
Shari Pilon-Thomas, Krithika N Kodumudi, +8 authors, Robert J Gillies.
Cancer Res, 2016 Jan 01; 76(6). PMID: 26719539    Free PMC article.
Highly Cited.
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance.
David H Munn, Andrew L Mellor.
Trends Immunol, 2016 Feb 04; 37(3). PMID: 26839260    Free PMC article.
Highly Cited. Review.
Interleukin-35 Limits Anti-Tumor Immunity.
Meghan E Turnis, Deepali V Sawant, +7 authors, Dario A A Vignali.
Immunity, 2016 Feb 14; 44(2). PMID: 26872697    Free PMC article.
Highly Cited.
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.
Shohei Koyama, Esra A Akbay, +23 authors, Peter S Hammerman.
Nat Commun, 2016 Feb 18; 7. PMID: 26883990    Free PMC article.
Highly Cited.
PD-1 expression conditions T cell avidity within an antigen-specific repertoire.
Sylvain Simon, Virginie Vignard, +4 authors, N Labarriere.
Oncoimmunology, 2016 Mar 05; 5(1). PMID: 26942093    Free PMC article.
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.
Louis Fehrenbacher, Alexander Spira, +16 authors, POPLAR Study Group.
Lancet, 2016 Mar 14; 387(10030). PMID: 26970723
Highly Cited.
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
Paul T Nghiem, Shailender Bhatia, +28 authors, Martin A Cheever.
N Engl J Med, 2016 Apr 20; 374(26). PMID: 27093365    Free PMC article.
Highly Cited.
Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model.
Eloah Rabello Suarez, De Kuan Chang, +5 authors, Wayne A Marasco.
Oncotarget, 2016 May 05; 7(23). PMID: 27145284    Free PMC article.
Highly Cited.
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
Jesse M Zaretsky, Angel Garcia-Diaz, +26 authors, Antoni Ribas.
N Engl J Med, 2016 Jul 20; 375(9). PMID: 27433843    Free PMC article.
Highly Cited.
Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion.
Eunseon Ahn, Ben Youngblood, +3 authors, Rafi Ahmed.
J Virol, 2016 Jul 29; 90(19). PMID: 27466420    Free PMC article.
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
Se Jin Im, Masao Hashimoto, +13 authors, Rafi Ahmed.
Nature, 2016 Aug 09; 537(7620). PMID: 27501248    Free PMC article.
Highly Cited.
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.
Andrea Schietinger, Mary Philip, +10 authors, Philip D Greenberg.
Immunity, 2016 Aug 16; 45(2). PMID: 27521269    Free PMC article.
Highly Cited.
The biology and function of fibroblasts in cancer.
Raghu Kalluri.
Nat Rev Cancer, 2016 Aug 24; 16(9). PMID: 27550820
Highly Cited. Review.
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade.
Kristen E Pauken, Morgan A Sammons, +16 authors, E John Wherry.
Science, 2016 Oct 30; 354(6316). PMID: 27789795    Free PMC article.
Highly Cited.
The epigenetic landscape of T cell exhaustion.
Debattama R Sen, James Kaminski, +16 authors, W Nicholas Haining.
Science, 2016 Oct 30; 354(6316). PMID: 27789799    Free PMC article.
Highly Cited.
CAR T Cell Therapy for Solid Tumors.
Kheng Newick, Shaun O'Brien, Edmund Moon, Steven M Albelda.
Annu Rev Med, 2016 Nov 20; 68. PMID: 27860544
Highly Cited. Review.
IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus.
S Drennan, A D'Avola, +11 authors, F Forconi.
Leukemia, 2016 Nov 29; 31(8). PMID: 27890932
Regulatory T cells in cancer immunotherapy.
Atsushi Tanaka, Shimon Sakaguchi.
Cell Res, 2016 Dec 21; 27(1). PMID: 27995907    Free PMC article.
Highly Cited. Review.
Tumor antigen-specific CD8+ T cells are negatively regulated by PD-1 and Tim-3 in human gastric cancer.
Xu Lu, Lin Yang, +8 authors, Jingwei Liu.
Cell Immunol, 2017 Jan 24; 313. PMID: 28110884
Shaping of Peripheral T Cell Responses by Lymphatic Endothelial Cells.
Marion Humbert, Stéphanie Hugues, Juan Dubrot.
Front Immunol, 2017 Jan 28; 7. PMID: 28127298    Free PMC article.
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy.
Paul A Beavis, Melissa A Henderson, +15 authors, Phillip K Darcy.
J Clin Invest, 2017 Feb 07; 127(3). PMID: 28165340    Free PMC article.
Highly Cited.
Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer.
Gulidanna Shayan, Raghvendra Srivastava, +3 authors, Robert L Ferris.
Oncoimmunology, 2017 Feb 16; 6(1). PMID: 28197389    Free PMC article.
Highly Cited.
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.
Enfu Hui, Jeanne Cheung, +8 authors, Ronald D Vale.
Science, 2017 Mar 11; 355(6332). PMID: 28280247    Free PMC article.
Highly Cited.
Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.
Alice O Kamphorst, Andreas Wieland, +17 authors, Rafi Ahmed.
Science, 2017 Mar 11; 355(6332). PMID: 28280249    Free PMC article.
Highly Cited.
Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via β-hydroxybutyrate.
Chun-Kai Huang, Po-Hao Chang, +6 authors, Wen-Hwa Lee.
Nat Commun, 2017 Mar 11; 8. PMID: 28281525    Free PMC article.
Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells.
Giuliana P Mognol, Roberto Spreafico, +6 authors, Sara Trifari.
Proc Natl Acad Sci U S A, 2017 Mar 12; 114(13). PMID: 28283662    Free PMC article.
Highly Cited.
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells.
Levi J Rupp, Kathrin Schumann, +4 authors, Alexander Marson.
Sci Rep, 2017 Apr 09; 7(1). PMID: 28389661    Free PMC article.
Highly Cited.
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia.
Guoqing Wei, Lijuan Ding, +2 authors, He Huang.
Exp Hematol Oncol, 2017 Apr 18; 6. PMID: 28413717    Free PMC article.
Highly Cited. Review.
Immunotherapy in hematologic malignancies: past, present, and future.
Annie Im, Steven Z Pavletic.
J Hematol Oncol, 2017 Apr 25; 10(1). PMID: 28434396    Free PMC article.
Combined Anti-VEGF and Anti-CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes.
Xinqi Wu, Jingjing Li, +12 authors, F Stephen Hodi.
Cancer Immunol Res, 2017 May 06; 5(6). PMID: 28473314    Free PMC article.
Chromatin states define tumour-specific T cell dysfunction and reprogramming.
Mary Philip, Lauren Fairchild, +11 authors, Andrea Schietinger.
Nature, 2017 May 18; 545(7655). PMID: 28514453    Free PMC article.
Highly Cited.
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, +43 authors, Luis A Diaz.
Science, 2017 Jun 10; 357(6349). PMID: 28596308    Free PMC article.
Highly Cited.
CRISPR-Cas9 mediated LAG-3 disruption in CAR-T cells.
Yongping Zhang, Xingying Zhang, +7 authors, Haoyi Wang.
Front Med, 2017 Jun 19; 11(4). PMID: 28625015
Highly Cited.
Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia.
Liuluan Zhu, Yaxian Kong, +11 authors, Hong Zheng.
J Hematol Oncol, 2017 Jun 21; 10(1). PMID: 28629373    Free PMC article.
De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation.
Hazem E Ghoneim, Yiping Fan, +8 authors, Ben Youngblood.
Cell, 2017 Jun 27; 170(1). PMID: 28648661    Free PMC article.
Highly Cited.
From Krebs to clinic: glutamine metabolism to cancer therapy.
Brian J Altman, Zachary E Stine, Chi V Dang.
Nat Rev Cancer, 2017 Jul 14; 16(11). PMID: 28704361
Highly Cited.
Identification of essential genes for cancer immunotherapy.
Shashank J Patel, Neville E Sanjana, +21 authors, Nicholas P Restifo.
Nature, 2017 Aug 08; 548(7669). PMID: 28783722    Free PMC article.
Highly Cited.
Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis.
Rajeev K Shrimali, Shamim Ahmad, +12 authors, Samir N Khleif.
Cancer Immunol Res, 2017 Aug 30; 5(9). PMID: 28848055
Highly Cited.
Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy.
Ying Zhang, Raj Kurupati, +17 authors, Hildegund C J Ertl.
Cancer Cell, 2017 Sep 13; 32(3). PMID: 28898698    Free PMC article.
Highly Cited.
Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function.
Yael Gropper, Tali Feferman, +3 authors, Guy Shakhar.
Cell Rep, 2017 Sep 14; 20(11). PMID: 28903036
Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor-Modified T Cells Engineered to Secrete Checkpoint Inhibitors.
Si Li, Natnaree Siriwon, +9 authors, Pin Wang.
Clin Cancer Res, 2017 Sep 16; 23(22). PMID: 28912137
Highly Cited.
FOXO1 opposition of CD8+ T cell effector programming confers early memory properties and phenotypic diversity.
Arnaud Delpoux, Chen-Yen Lai, Stephen M Hedrick, Andrew L Doedens.
Proc Natl Acad Sci U S A, 2017 Oct 05; 114(42). PMID: 28973925    Free PMC article.
The diverse functions of the PD1 inhibitory pathway.
Arlene H Sharpe, Kristen E Pauken.
Nat Rev Immunol, 2017 Oct 11; 18(3). PMID: 28990585
Highly Cited. Review.
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer.
Purushottam Lamichhane, Lavakumar Karyampudi, +8 authors, Keith L Knutson.
Cancer Res, 2017 Oct 11; 77(23). PMID: 28993412    Free PMC article.
Suppression of FIP200 and autophagy by tumor-derived lactate promotes naïve T cell apoptosis and affects tumor immunity.
Houjun Xia, Wei Wang, +12 authors, Weiping Zou.
Sci Immunol, 2017 Nov 19; 2(17). PMID: 29150439    Free PMC article.
Transcription Factor IRF4 Promotes CD8+ T Cell Exhaustion and Limits the Development of Memory-like T Cells during Chronic Infection.
Kevin Man, Sarah S Gabriel, +9 authors, Axel Kallies.
Immunity, 2017 Dec 17; 47(6). PMID: 29246443
Highly Cited.
Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution.
Mirjana Efremova, Dietmar Rieder, +8 authors, Zlatko Trajanoski.
Nat Commun, 2018 Jan 04; 9(1). PMID: 29296022    Free PMC article.
Highly Cited.
High response rate to PD-1 blockade in desmoplastic melanomas.
Zeynep Eroglu, Jesse M Zaretsky, +22 authors, Antoni Ribas.
Nature, 2018 Jan 11; 553(7688). PMID: 29320474    Free PMC article.
Highly Cited.
Hypoxia-inducible factor-1α is a critical transcription factor for IL-10-producing B cells in autoimmune disease.
Xianyi Meng, Bettina Grötsch, +7 authors, Aline Bozec.
Nat Commun, 2018 Jan 19; 9(1). PMID: 29343683    Free PMC article.
Highly Cited.
Myeloid-derived suppressor cells coming of age.
Filippo Veglia, Michela Perego, Dmitry Gabrilovich.
Nat Immunol, 2018 Jan 20; 19(2). PMID: 29348500    Free PMC article.
Highly Cited. Review.
Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T.
Dok Hyun Yoon, Mark J Osborn, Jakub Tolar, Chong Jai Kim.
Int J Mol Sci, 2018 Jan 25; 19(2). PMID: 29364163    Free PMC article.
Highly Cited. Review.
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma.
Xin Li, Yasong Cheng, +15 authors, Ken H Young.
J Hematol Oncol, 2018 Feb 02; 11(1). PMID: 29386072    Free PMC article.
Highly Cited.
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Sanjeev Mariathasan, Shannon J Turley, +39 authors, Thomas Powles.
Nature, 2018 Feb 15; 554(7693). PMID: 29443960    Free PMC article.
Highly Cited.
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis.
Daniele V F Tauriello, Sergio Palomo-Ponce, +15 authors, Eduard Batlle.
Nature, 2018 Feb 15; 554(7693). PMID: 29443964
Highly Cited.
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells.
Matthew A Lakins, Ehsan Ghorani, +2 authors, Jacqueline D Shields.
Nat Commun, 2018 Mar 07; 9(1). PMID: 29507342    Free PMC article.
Highly Cited.
Driving T-cell immunotherapy to solid tumors.
Ken Garber.
Nat Biotechnol, 2018 Mar 07; 36(3). PMID: 29509745
Next generation of immune checkpoint therapy in cancer: new developments and challenges.
Julian A Marin-Acevedo, Bhagirathbhai Dholaria, +3 authors, Yanyan Lou.
J Hematol Oncol, 2018 Mar 17; 11(1). PMID: 29544515    Free PMC article.
Highly Cited. Review.
Cancer immunotherapy using checkpoint blockade.
Antoni Ribas, Jedd D Wolchok.
Science, 2018 Mar 24; 359(6382). PMID: 29567705    Free PMC article.
Highly Cited. Review.
Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia.
Jiang Cao, Gang Wang, +15 authors, Kailin Xu.
Am J Hematol, 2018 Apr 11; 93(7). PMID: 29633386
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.
Qian Huang, Jiajia Xia, +12 authors, Yong Li.
J Hematol Oncol, 2018 Apr 25; 11(1). PMID: 29685162    Free PMC article.
Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells.
Bian Hu, Yan Zou, +5 authors, Xuekai Zhu.
Hum Gene Ther, 2018 May 01; 30(4). PMID: 29706119
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Joseph A Fraietta, Simon F Lacey, +34 authors, J Joseph Melenhorst.
Nat Med, 2018 May 02; 24(5). PMID: 29713085    Free PMC article.
Highly Cited.
Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma.
Xinqi Wu, Anita Giobbie-Hurder, +6 authors, F Stephen Hodi.
Oncoimmunology, 2018 Jun 15; 7(7). PMID: 29900046    Free PMC article.
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo.
Sarwish Rafiq, Oladapo O Yeku, +14 authors, Renier J Brentjens.
Nat Biotechnol, 2018 Aug 14; 36(9). PMID: 30102295    Free PMC article.
Highly Cited.
Tim-3 expression and its role in hepatocellular carcinoma.
Feifei Liu, Yanning Liu, Zhi Chen.
J Hematol Oncol, 2018 Oct 13; 11(1). PMID: 30309387    Free PMC article.
Programmed cell death protein 1 activation preferentially inhibits CD28.CAR-T cells.
Sergey N Zolov, Skyler P Rietberg, Challice L Bonifant.
Cytotherapy, 2018 Oct 13; 20(10). PMID: 30309710
Regulatory T cells in the treatment of disease.
Amir Sharabi, Maria G Tsokos, +3 authors, George C Tsokos.
Nat Rev Drug Discov, 2018 Oct 13; 17(11). PMID: 30310234
Highly Cited. Review.
Cancer immunotherapy: challenges and clinical applications.
An-Liang Xia, Yong Xu, Xiao-Jie Lu.
J Med Genet, 2018 Nov 23; 56(1). PMID: 30464054
Turning foes to friends: targeting cancer-associated fibroblasts.
Xueman Chen, Erwei Song.
Nat Rev Drug Discov, 2018 Nov 25; 18(2). PMID: 30470818
Highly Cited. Review.
The Yin and Yang of Myeloid Derived Suppressor Cells.
Snehil Budhwar, Priyanka Verma, +2 authors, Kiran Singh.
Front Immunol, 2018 Dec 18; 9. PMID: 30555467    Free PMC article.
Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients.
Bixia Tang, Xieqiao Yan, +20 authors, Jun Guo.
J Hematol Oncol, 2019 Jan 16; 12(1). PMID: 30642373    Free PMC article.
Highly Cited.
The evolving role of T-bet in resistance to infection.
Gretchen Harms Pritchard, Ross M Kedl, Christopher A Hunter.
Nat Rev Immunol, 2019 Mar 09; 19(6). PMID: 30846856    Free PMC article.
Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion.
Deepali V Sawant, Hiroshi Yano, +16 authors, Dario A A Vignali.
Nat Immunol, 2019 Apr 03; 20(6). PMID: 30936494    Free PMC article.
Highly Cited.
TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion.
Hyungseok Seo, Joyce Chen, +12 authors, Anjana Rao.
Proc Natl Acad Sci U S A, 2019 Jun 04; 116(25). PMID: 31152140    Free PMC article.
Highly Cited.
TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma.
Xiaochen Wang, Qifeng He, +4 authors, Beicheng Sun.
J Hepatol, 2019 Jun 08; 71(4). PMID: 31173813
Highly Cited.
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion.
Omar Khan, Josephine R Giles, +22 authors, E John Wherry.
Nature, 2019 Jun 18; 571(7764). PMID: 31207603    Free PMC article.
Highly Cited.
Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma.
L Piali, A Fichtel, +2 authors, R H Gisler.
J Exp Med, 1995 Feb 01; 181(2). PMID: 7530765    Free PMC article.
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
P S Linsley, J L Greene, +3 authors, R Peach.
Immunity, 1994 Dec 01; 1(9). PMID: 7534620
Highly Cited.
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
M F Krummel, J P Allison.
J Exp Med, 1995 Aug 01; 182(2). PMID: 7543139    Free PMC article.
Highly Cited.
Inducible T cell antigen 4-1BB. Analysis of expression and function.
K E Pollok, Y J Kim, +4 authors, B S Kwon.
J Immunol, 1993 Feb 01; 150(3). PMID: 7678621
Highly Cited.
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.
D I Gabrilovich, H L Chen, +5 authors, D P Carbone.
Nat Med, 1996 Oct 01; 2(10). PMID: 8837607
Highly Cited.
Viral immune evasion due to persistence of activated T cells without effector function.
A J Zajac, J N Blattman, +4 authors, R Ahmed.
J Exp Med, 1998 Dec 22; 188(12). PMID: 9858507    Free PMC article.
Highly Cited.
Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy.
Benjamin Faist, Fabian Schlott, +11 authors, Michael Neuenhahn.
PLoS One, 2019 Oct 01; 14(9). PMID: 31568490    Free PMC article.
Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics.
Muhammad Haseeb, Rameez Hassan Pirzada, Qurat Ul Ain, Sangdun Choi.
Cells, 2019 Nov 07; 8(11). PMID: 31684152    Free PMC article.
Photochemical Internalization: Light Paves Way for New Cancer Chemotherapies and Vaccines.
Lara Šošić, Pål Kristian Selbo, +3 authors, Pål Johansen.
Cancers (Basel), 2020 Jan 16; 12(1). PMID: 31936595    Free PMC article.
T Cell Dysfunction and Exhaustion in Cancer.
Zhen Zhang, Shasha Liu, +3 authors, Yi Zhang.
Front Cell Dev Biol, 2020 Mar 03; 8. PMID: 32117960    Free PMC article.
Heterogeneity of Human γδ T Cells and Their Role in Cancer Immunity.
Hye Won Lee, Yun Shin Chung, Tae Jin Kim.
Immune Netw, 2020 Mar 12; 20(1). PMID: 32158593    Free PMC article.
Extracellular Vesicles and Tumor-Immune Escape: Biological Functions and Clinical Perspectives.
Stefania Raimondo, Marzia Pucci, Riccardo Alessandro, Simona Fontana.
Int J Mol Sci, 2020 Apr 01; 21(7). PMID: 32225076    Free PMC article.
From Theranostics to Immunotheranostics: the Concept.
Niklaus Schaefer, John O Prior, Margret Schottelius.
Nucl Med Mol Imaging, 2020 May 08; 54(2). PMID: 32377259    Free PMC article.
Immunomodulatory effects of renin-angiotensin system inhibitors on T lymphocytes in mice with colorectal liver metastases.
Dora Lucia Vallejo Ardila, Katrina A Walsh, +4 authors, Marcos Vinicius Perini.
J Immunother Cancer, 2020 May 26; 8(1). PMID: 32448803    Free PMC article.
Kaempferol and Its Glycoside, Kaempferol 7-O-Rhamnoside, Inhibit PD-1/PD-L1 Interaction In Vitro.
Ji Hye Kim, Young Soo Kim, +5 authors, Hwan-Suck Chung.
Int J Mol Sci, 2020 May 08; 21(9). PMID: 32375257    Free PMC article.
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials.
Omid Kooshkaki, Afshin Derakhshani, +6 authors, Behzad Baradaran.
Int J Mol Sci, 2020 Jun 26; 21(12). PMID: 32580338    Free PMC article.
Stem cell programs in cancer initiation, progression, and therapy resistance.
Tianzhi Huang, Xiao Song, +6 authors, Shi-Yuan Cheng.
Theranostics, 2020 Aug 06; 10(19). PMID: 32754274    Free PMC article.
Lentinan Inhibits Tumor Progression by Immunomodulation in a Mouse Model of Bladder Cancer.
Ming Sun, Renge Bu, +3 authors, Wenyan Zhao.
Integr Cancer Ther, 2020 Aug 01; 19. PMID: 32735179    Free PMC article.
Immunotherapies and Combination Strategies for Immuno-Oncology.
Cody Barbari, Tyler Fontaine, +4 authors, Rahul R Deshmukh.
Int J Mol Sci, 2020 Jul 19; 21(14). PMID: 32679922    Free PMC article.
Association of Hydrophobic Carboxyl-Terminal Dendrimers with Lymph Node-Resident Lymphocytes.
Yutaka Nishimoto, Misaki Nishio, +9 authors, Chie Kojima.
Polymers (Basel), 2020 Jul 08; 12(7). PMID: 32630042    Free PMC article.
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types.
Jasneet Kaur Khalsa, Nina Cheng, +5 authors, Khalid Shah.
Nat Commun, 2020 Aug 09; 11(1). PMID: 32764562    Free PMC article.
Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma.
Zachary Jackson, Anne Roe, +21 authors, Jane S Reese.
Front Immunol, 2020 Aug 28; 11. PMID: 32849651    Free PMC article.
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.
Jason K Sa, Nakho Chang, +32 authors, Do-Hyun Nam.
Genome Biol, 2020 Aug 28; 21(1). PMID: 32847614    Free PMC article.
"Re-educating" Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma.
Kevin X Liu, Shweta Joshi.
Front Immunol, 2020 Sep 29; 11. PMID: 32983125    Free PMC article.
Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer.
Reem Saleh, Rowaida Z Taha, +7 authors, Eyad Elkord.
Cancer Immunol Immunother, 2020 May 13; 69(10). PMID: 32393998    Free PMC article.
Differential gene expression of tumor-infiltrating CD8+ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis.
Reem Saleh, Varun Sasidharan Nair, +8 authors, Eyad Elkord.
J Immunother Cancer, 2020 Sep 20; 8(2). PMID: 32948653    Free PMC article.
Spontaneous and Induced Animal Models for Cancer Research.
Anca Onaciu, Raluca Munteanu, +8 authors, Ioana Berindan-Neagoe.
Diagnostics (Basel), 2020 Sep 04; 10(9). PMID: 32878340    Free PMC article.
Helpless Priming Sends CD8+ T Cells on the Road to Exhaustion.
Julia Busselaar, Sun Tian, Hans van Eenennaam, Jannie Borst.
Front Immunol, 2020 Oct 31; 11. PMID: 33123174    Free PMC article.
Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy.
Italia Falcone, Fabiana Conciatori, +4 authors, Michele Milella.
Cancers (Basel), 2020 Oct 11; 12(10). PMID: 33036192    Free PMC article.
Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment.
Xingyi Pan, Lei Zheng.
Cell Mol Immunol, 2020 Jul 24; 17(9). PMID: 32699350    Free PMC article.
Tackling TAMs for Cancer Immunotherapy: It's Nano Time.
Yishun Yang, Jianfeng Guo, Leaf Huang.
Trends Pharmacol Sci, 2020 Sep 19; 41(10). PMID: 32946772    Free PMC article.
Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies.
Kaijian Zhou, Shu Guo, +2 authors, Guoxin Liang.
Front Cell Dev Biol, 2020 Nov 13; 8. PMID: 33178688    Free PMC article.
Distinct peripheral blood molecular signature emerges with successful tacrolimus withdrawal in kidney transplant recipients.
Paolo Cravedi, Miguel Fribourg, +7 authors, Peter S Heeger.
Am J Transplant, 2020 May 28; 20(12). PMID: 32459070    Free PMC article.
CRISPR-Based Editing Techniques for Genetic Manipulation of Primary T Cells.
Mateusz Kotowski, Sumana Sharma.
Methods Protoc, 2020 Nov 22; 3(4). PMID: 33217926    Free PMC article.
Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver.
Lei Liu, Bolei Dai, +2 authors, Zhihong Zhang.
Theranostics, 2021 Jan 05; 11(1). PMID: 33391470    Free PMC article.
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.
Daan P Hurkmans, Els M E Verdegaal, +18 authors, Sjoerd H van der Burg.
J Immunother Cancer, 2021 Jan 12; 8(2). PMID: 33427690    Free PMC article.
The Cxxc1 subunit of the Trithorax complex directs epigenetic licensing of CD4+ T cell differentiation.
Masahiro Kiuchi, Atsushi Onodera, +8 authors, Toshinori Nakayama.
J Exp Med, 2021 Jan 13; 218(4). PMID: 33433611    Free PMC article.
The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma?
Eduardo Fleury, Cristiane Nimir, Gabriel Salum D'Alessandro.
Breast Cancer (Dove Med Press), 2021 Jan 26; 13. PMID: 33488119    Free PMC article.
The Adhesome Network: Key Components Shaping the Tumour Stroma.
Pinelopi A Nikolopoulou, Maria A Koufaki, Vassiliki Kostourou.
Cancers (Basel), 2021 Feb 13; 13(3). PMID: 33573141    Free PMC article.
Using CRISPR to enhance T cell effector function for therapeutic applications.
Julian J Freen-van Heeren.
Cytokine X, 2021 Feb 20; 3(1). PMID: 33604565    Free PMC article.
The current landscape of single-cell transcriptomics for cancer immunotherapy.
Puneeth Guruprasad, Yong Gu Lee, Ki Hyun Kim, Marco Ruella.
J Exp Med, 2021 Feb 19; 218(1). PMID: 33601414    Free PMC article.
Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.
Apryl S Saunders, Dawn E Bender, +2 authors, Katherine T Morris.
PLoS One, 2021 Feb 20; 16(2). PMID: 33606788    Free PMC article.
Ubiquitination of Nonhistone Proteins in Cancer Development and Treatment.
Xiuzhen Zhang, Tong Meng, +4 authors, Ping Wang.
Front Oncol, 2021 Mar 02; 10. PMID: 33643919    Free PMC article.
Low-grade chronic inflammation and immune alterations in childhood and adolescent cancer survivors: A contribution to accelerated aging?
Joanna Sulicka-Grodzicka, Andrzej Surdacki, +4 authors, Tomasz Grodzicki.
Cancer Med, 2021 Feb 20; 10(5). PMID: 33605556    Free PMC article.
A New Method for Optimizing Sepsis Therapy by Nivolumab and Meropenem Combination: Importance of Early Intervention and CTL Reinvigoration Rate as a Response Marker.
Avi Gillis, Anat Ben Yaacov, Zvia Agur.
Front Immunol, 2021 Mar 19; 12. PMID: 33732241    Free PMC article.
Lipid Metabolism in Tumor-Infiltrating T Cells.
Shangwen He, Ting Cai, +2 authors, Wei Yang.
Adv Exp Med Biol, 2021 Mar 20; 1316. PMID: 33740249
Next generation of immune checkpoint inhibitors and beyond.
Julian A Marin-Acevedo, ErinMarie O Kimbrough, Yanyan Lou.
J Hematol Oncol, 2021 Mar 21; 14(1). PMID: 33741032    Free PMC article.
Low-Dose Decitabine Augments the Activation and Anti-Tumor Immune Response of IFN-γ+ CD4+ T Cells Through Enhancing IκBα Degradation and NF-κB Activation.
Xiang Li, Liang Dong, +6 authors, Jing Nie.
Front Cell Dev Biol, 2021 Apr 02; 9. PMID: 33791306    Free PMC article.
Progression of Metastasis through Lymphatic System.
Hengbo Zhou, Pin-Ji Lei, Timothy P Padera.
Cells, 2021 Apr 04; 10(3). PMID: 33808959    Free PMC article.
Nanoparticles for Enhanced Adoptive T Cell Therapies and Future Perspectives for CNS Tumors.
Preethi Bala Balakrishnan, Elizabeth E Sweeney.
Front Immunol, 2021 Apr 10; 12. PMID: 33833751    Free PMC article.
Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy.
Benedetta Apollonio, Nikolaos Ioannou, Despoina Papazoglou, Alan G Ramsay.
Front Oncol, 2021 Apr 13; 11. PMID: 33842331    Free PMC article.
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review.
Chang Liu, Navindra P Seeram, Hang Ma.
Cancer Cell Int, 2021 Apr 29; 21(1). PMID: 33906641    Free PMC article.
Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity.
Won Suk Lee, Hannah Yang, Hong Jae Chon, Chan Kim.
Exp Mol Med, 2020 Sep 12; 52(9). PMID: 32913278    Free PMC article.
Tissues and Tumor Microenvironment (TME) in 3D: Models to Shed Light on Immunosuppression in Cancer.
Teresa Ho, Rasha Msallam.
Cells, 2021 May 01; 10(4). PMID: 33917037    Free PMC article.
Ex Vivo High Salt Activated Tumor-Primed CD4+T Lymphocytes Exert a Potent Anti-Cancer Response.
Venkataswarup Tiriveedhi, Michael T Ivy, +3 authors, Jens Titze.
Cancers (Basel), 2021 May 01; 13(7). PMID: 33918403    Free PMC article.
A Review of Proteomics Strategies to Study T-Cell Activation and Function in Cancer Disease.
Massimo Papale.
Methods Mol Biol, 2021 May 31; 2325. PMID: 34053055
Recent Advances on Immune Targeted Therapy of Colorectal Cancer Using bi-Specific Antibodies and Therapeutic Vaccines.
Ali Azadi, Alireza Golchini, +4 authors, Shirin Eyvazi.
Biol Proced Online, 2021 Jul 02; 23(1). PMID: 34193050    Free PMC article.
Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma.
Byung-Hyun Lee, Yong Park, +4 authors, Byung Soo Kim.
Front Oncol, 2021 Jul 02; 11. PMID: 34195077    Free PMC article.
Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers.
Mark A Baxter, Fearghas Middleton, Hannah P Cagney, Russell D Petty.
Br J Cancer, 2021 Jul 08; 125(8). PMID: 34230609    Free PMC article.
T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia.
Elisavet Vlachonikola, Kostas Stamatopoulos, Anastasia Chatzidimitriou.
Cancers (Basel), 2021 Jul 03; 13(13). PMID: 34209724    Free PMC article.
The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy.
Bonnie L Russell, Selisha A Sooklal, +2 authors, Monde Ntwasa.
Front Oncol, 2021 Jul 17; 11. PMID: 34268109    Free PMC article.
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines.
Alexander J Stephens, Nicola A Burgess-Brown, Shisong Jiang.
Front Immunol, 2021 Jul 20; 12. PMID: 34276688    Free PMC article.
The therapeutic and prognostic implications of immunobiology in colorectal cancer: a review.
Alexandra M Zaborowski, Des C Winter, Lydia Lynch.
Br J Cancer, 2021 Jul 25; 125(10). PMID: 34302062    Free PMC article.
Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes.
Ting Zhou, Ping Yang, +6 authors, Liang Li.
J Oncol, 2021 Aug 10; 2021. PMID: 34367284    Free PMC article.
Cellular based immunotherapy for primary liver cancer.
Yuanyuan Zheng, Yan Li, +8 authors, Chuanyong Guo.
J Exp Clin Cancer Res, 2021 Aug 11; 40(1). PMID: 34372912    Free PMC article.
Dynamic chromatin regulatory landscape of human CAR T cell exhaustion.
David G Gennert, Rachel C Lynn, +10 authors, Howard Y Chang.
Proc Natl Acad Sci U S A, 2021 Jul 22; 118(30). PMID: 34285077    Free PMC article.
An Engineered Prussian Blue Nanoparticles-based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH-MYCN Neuroblastoma Model.
Anshi Shukla, Juliana Cano-Mejia, +3 authors, Rohan Fernandes.
Adv Nanobiomed Res, 2021 Aug 27; 1(8). PMID: 34435194    Free PMC article.
Novel Insights into the Immunotherapy of Soft Tissue Sarcomas: Do We Need a Change of Perspective?
Andrej Ozaniak, Jiri Vachtenheim, +2 authors, Zuzana Strizova.
Biomedicines, 2021 Aug 28; 9(8). PMID: 34440139    Free PMC article.
Novel diagnostic and prognostic biomarkers of colorectal cancer: Capable to overcome the heterogeneity-specific barrier and valid for global applications.
Yasir Hameed, Muhammad Usman, Shufang Liang, Samina Ejaz.
PLoS One, 2021 Sep 03; 16(9). PMID: 34473751    Free PMC article.
Carrelizumab combined with anlotinib in the treatment of extensive-stage small cell lung cancer: A case report.
Liang Liu, Xin Zhang, +3 authors, Xiaodong Jiang.
Medicine (Baltimore), 2021 Sep 04; 100(35). PMID: 34477165    Free PMC article.
MMP25-AS1/hsa-miR-10a-5p/SERPINE1 axis as a novel prognostic biomarker associated with immune cell infiltration in KIRC.
Peng Tan, Hao Chen, +6 authors, Wenguang Fu.
Mol Ther Oncolytics, 2021 Sep 24; 22. PMID: 34553021    Free PMC article.
Cytomegalovirus retinitis in patients of non-Hodgkin's lymphoma: clinical presentations and outcomes.
Subhakar Reddy, Mudit Tyagi, +4 authors, Hitesh Agrawal.
J Ophthalmic Inflamm Infect, 2021 Oct 07; 11(1). PMID: 34611773    Free PMC article.
Improving CAR T-Cell Persistence.
Violena Pietrobon, Lauren Anne Todd, +3 authors, Francesco Marincola.
Int J Mol Sci, 2021 Oct 14; 22(19). PMID: 34639168    Free PMC article.
Dietary Fats High in Linoleic Acids Impair Antitumor T-cell Responses by Inducing E-FABP-Mediated Mitochondrial Dysfunction.
Rong Jin, Jiaqing Hao, +8 authors, Bing Li.
Cancer Res, 2021 Aug 18; 81(20). PMID: 34400394    Free PMC article.
Multifunctional silica nanocomposites prime tumoricidal immunity for efficient cancer immunotherapy.
Linnan Yang, Feng Li, +7 authors, Ang Li.
J Nanobiotechnology, 2021 Oct 20; 19(1). PMID: 34663354    Free PMC article.
CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?
Alexandra M Miggelbrink, Joshua D Jackson, +4 authors, Peter E Fecci.
Clin Cancer Res, 2021 Jun 16; 27(21). PMID: 34127507    Free PMC article.
Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors.
Fatma Babikr, Jiangbo Wan, +10 authors, Jim Xiang.
Cell Mol Immunol, 2021 Nov 17; 18(12). PMID: 34782757    Free PMC article.
Drug-eluting immune checkpoint blockade antibody-nanoparticle conjugate enhances locoregional and systemic combination cancer immunotherapy through T lymphocyte targeting.
David M Francis, Margaret P Manspeaker, +4 authors, Susan N Thomas.
Biomaterials, 2021 Oct 23; 279. PMID: 34678650    Free PMC article.
T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma.
Ellen E Sparger, Hong Chang, +6 authors, Michael S Kent.
Front Vet Sci, 2021 Dec 21; 8. PMID: 34926643    Free PMC article.
Resistance to Immunotherapy: Mechanisms and Means for Overcoming.
Mohamad A Salkeni, John Y Shin, James L Gulley.
Adv Exp Med Biol, 2022 Jan 02; 1342. PMID: 34972962
Targeting the ERβ/HER Oncogenic Network in KRAS Mutant Lung Cancer Modulates the Tumor Microenvironment and Is Synergistic with Sequential Immunotherapy.
Abdulaziz A Almotlak, Mariya Farooqui, +2 authors, Laura P Stabile.
Int J Mol Sci, 2022 Jan 12; 23(1). PMID: 35008514    Free PMC article.
Signatures and Specificity of Tissue-Resident Lymphocytes Identified in Human Renal Peritumor and Tumor Tissue.
Theresa Dornieden, Arne Sattler, +10 authors, Katja Kotsch.
J Am Soc Nephrol, 2021 Jun 03; 32(9). PMID: 34074699    Free PMC article.
T cells in pancreatic cancer stroma.
Michelle R Goulart, Konstantinos Stasinos, +2 authors, Hemant M Kocher.
World J Gastroenterol, 2022 Jan 21; 27(46). PMID: 35046623    Free PMC article.
Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1.
Dafne C A Quixabeira, Victor Cervera-Carrascon, +9 authors, Akseli Hemminki.
Oncoimmunology, 2022 Jan 28; 11(1). PMID: 35083096    Free PMC article.
Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumor immunity.
Máté Manczinger, Balázs Koncz, +5 authors, Csaba Pál.
Nat Cancer, 2022 Feb 06; 2(9). PMID: 35121862
Impaired CXCL12 signaling contributes to resistance of pancreatic cancer subpopulations to T cell-mediated cytotoxicity.
Yuan-Na Lin, Marcel O Schmidt, +5 authors, Anton Wellstein.
Oncoimmunology, 2022 Feb 08; 11(1). PMID: 35127250    Free PMC article.
Machine Learning of Single Cell Transcriptomic Data From anti-PD-1 Responders and Non-responders Reveals Distinct Resistance Mechanisms in Skin Cancers and PDAC.
Ryan Liu, Emmanuel Dollinger, Qing Nie.
Front Genet, 2022 Feb 19; 12. PMID: 35178072    Free PMC article.
Circadian and Immunity Cycle Talk in Cancer Destination: From Biological Aspects to In Silico Analysis.
Mina Mirian, Amirali Hariri, Mahtasadat Yadollahi, Mohammad Kohandel.
Cancers (Basel), 2022 Mar 26; 14(6). PMID: 35326729    Free PMC article.
Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8+ T Cells in Immunotherapy-Resistant and Metastatic Cancers.
Jenny Dunn, Robert D McCuaig, +22 authors, Sudha Rao.
Cancers (Basel), 2022 Mar 26; 14(6). PMID: 35326747    Free PMC article.
Role of Senescence in Tumorigenesis and Anticancer Therapy.
Ewelina Stoczynska-Fidelus, Marta Węgierska, +2 authors, Piotr Rieske.
J Oncol, 2022 Mar 29; 2022. PMID: 35342397    Free PMC article.
CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical Perspectives.
Keywan Mortezaee, Jamal Majidpoor.
Front Immunol, 2022 Apr 19; 13. PMID: 35432340    Free PMC article.
Visual Analysis of Colorectal Cancer Immunotherapy: A Bibliometric Analysis From 2012 to 2021.
Long Ma, Jixiang Ma, Muzhou Teng, Yumin Li.
Front Immunol, 2022 Apr 19; 13. PMID: 35432385    Free PMC article.
Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades.
Cheng-Long Han, Yu-Chuan Yan, +8 authors, Tao Li.
J Cancer Res Clin Oncol, 2022 Apr 29;. PMID: 35482077
Immune checkpoint inhibitors for the treatment of melanoma.
Francesco Sabbatino, Luigi Liguori, Stefano Pepe, Soldano Ferrone.
Expert Opin Biol Ther, 2022 Feb 09; 22(5). PMID: 35130816    Free PMC article.
Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice.
Christina Bruss, Kerstin Kellner, +4 authors, Anja Kathrin Wege.
Cancers (Basel), 2022 May 15; 14(9). PMID: 35565343    Free PMC article.